2.67
price down icon3.61%   -0.10
after-market After Hours: 2.63 -0.04 -1.50%
loading
Cardiff Oncology Inc stock is traded at $2.67, with a volume of 551.92K. It is down -3.61% in the last 24 hours and up +15.58% over the past month. Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
See More
Previous Close:
$2.77
Open:
$2.77
24h Volume:
551.92K
Relative Volume:
1.01
Market Cap:
$122.43M
Revenue:
$488.00K
Net Income/Loss:
$-41.44M
P/E Ratio:
-2.9667
EPS:
-0.9
Net Cash Flow:
$-31.47M
1W Performance:
+3.49%
1M Performance:
+15.58%
6M Performance:
-50.00%
1Y Performance:
+92.09%
1-Day Range:
Value
$2.61
$2.835
1-Week Range:
Value
$2.52
$2.88
52-Week Range:
Value
$0.94
$6.42

Cardiff Oncology Inc Stock (CRDF) Company Profile

Name
Name
Cardiff Oncology Inc
Name
Phone
858-952-7570
Name
Address
11055 FLINTKOTE AVENUE, SAN DIEGO, CA
Name
Employee
32
Name
Next Earnings Date
2024-08-08
Name
Latest SEC Filings
Name
CRDF's Discussions on Twitter

Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-05-22 Initiated William Blair Outperform
Dec-08-21 Initiated Robert W. Baird Outperform
Aug-09-21 Resumed Maxim Group Buy
Oct-22-20 Initiated H.C. Wainwright Buy
Oct-08-20 Initiated Piper Sandler Overweight

Cardiff Oncology Inc Stock (CRDF) Latest News

pulisher
01:25 AM

KRAS Inhibitors Market: New Treatments Are Set to Change Cancer Care | DelveInsight - 新浪香港

01:25 AM
pulisher
Sep 26, 2024

Blair William & Co. IL Raises Stake in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Sep 26, 2024
pulisher
Sep 25, 2024

Cardiff City . . . The Doom Loop Club Stuck On Groundhog Day - Dai Sport

Sep 25, 2024
pulisher
Sep 25, 2024

Investment Opportunities: Capitalizing on the Global Kras - openPR

Sep 25, 2024
pulisher
Sep 25, 2024

Cardiff City need 'long-term strategy' after Erol Bulut exitRob Earnshaw - BBC.com

Sep 25, 2024
pulisher
Sep 24, 2024

Tonight's Cardiff City news as 'stunned' club release statement and pundit picks 'fantastic' fit for job - Yahoo News UK

Sep 24, 2024
pulisher
Sep 24, 2024

Trading Day Review: Cardiff Oncology Inc (CRDF) Loses Momentum, Closing at 2.58 - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

CRDF (Cardiff Oncology Inc) has impressive results - US Post News

Sep 24, 2024
pulisher
Sep 24, 2024

Pompey Championship rival moves quickly to sort managerial mess after weekend sacking - Portsmouth News

Sep 24, 2024
pulisher
Sep 24, 2024

Cardiff going from 'one crisis to another' - Yahoo Sport Australia

Sep 24, 2024
pulisher
Sep 24, 2024

Next Cardiff City manager odds latest as Wales legend gatecrashes race - Yahoo News UK

Sep 24, 2024
pulisher
Sep 23, 2024

The surprise Welsh names leading the field to become new Cardiff City manager - Nation.Cymru

Sep 23, 2024
pulisher
Sep 23, 2024

Blackburn Rovers' rivals confirm third managerial casualty in the Championship - Lancashire Telegraph

Sep 23, 2024
pulisher
Sep 23, 2024

Cardiff City candidate 'would love' to manage club after already rescuing Vincent Tan - Wales Online

Sep 23, 2024
pulisher
Sep 22, 2024

Bluebirds give Bulut the bullet - MSN

Sep 22, 2024
pulisher
Sep 22, 2024

Next Cardiff manager odds: Erol Bulut sacked after poor start - Sportinglife.com

Sep 22, 2024
pulisher
Sep 22, 2024

SACKED! Cardiff axe Bulut - Tribal Football

Sep 22, 2024
pulisher
Sep 22, 2024

Cardiff City sack Erol Bulut as club seek new manager - Wales Online

Sep 22, 2024
pulisher
Sep 22, 2024

Next Cardiff Manager Odds: Who is favourite to replace Erol Bulut? - Oddschecker

Sep 22, 2024
pulisher
Sep 22, 2024

Middlesbrough and Sunderland rivals looking for new boss after swift sacking call - Yahoo Eurosport UK

Sep 22, 2024
pulisher
Sep 22, 2024

Cardiff City fire manager Erol Bulut - BBC

Sep 22, 2024
pulisher
Sep 21, 2024

Cardiff Capital Region invests £45m in Ogi to boost digital connectivity - South Wales Argus

Sep 21, 2024
pulisher
Sep 20, 2024

Market Watch Highlights: Cardiff Oncology Inc (CRDF) Ends on an Upturn Note at 2.53 - The Dwinnex

Sep 20, 2024
pulisher
Sep 20, 2024

Cardiff Oncology Inc (CRDF)’s results reveal risk - US Post News

Sep 20, 2024
pulisher
Sep 19, 2024

Tonight's Cardiff City news as Aaron Ramsey faces months out and Erol Bulut hits out over rumour - Wales Online

Sep 19, 2024
pulisher
Sep 19, 2024

Thoroughbred Financial Services LLC Makes New Investment in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Sep 19, 2024
pulisher
Sep 17, 2024

CEACAM5 Drugs Market Outlook: Rising Cancer Cases and Clinical Trials to Fuel Growth by 2034 | DelveInsight - PR Newswire UK

Sep 17, 2024
pulisher
Sep 16, 2024

Ready to Jump After Recent Trade: Cardiff Oncology Inc (CRDF) - SETE News

Sep 16, 2024
pulisher
Sep 13, 2024

CRDF’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Sep 13, 2024
pulisher
Sep 08, 2024

Craig Hallum Initiates Coverage on Cardiff Oncology (NASDAQ:CRDF) - Defense World

Sep 08, 2024
pulisher
Sep 06, 2024

Craig Hallum Initiates Coverage on Cardiff Oncology (NASDAQ:CRDF) - MarketBeat

Sep 06, 2024
pulisher
Sep 02, 2024

Cardiff Oncology, Inc. (NASDAQ:CRDF) Short Interest Up 16.3% in August - MarketBeat

Sep 02, 2024
pulisher
Sep 02, 2024

A better buy-in window may exist right now for Cardiff Oncology Inc (CRDF) - SETE News

Sep 02, 2024
pulisher
Aug 21, 2024

Cardiff Oncology, Inc. (NASDAQ:CRDF) Shares Purchased by Assenagon Asset Management S.A. - MarketBeat

Aug 21, 2024
pulisher
Aug 21, 2024

Assenagon Asset Management S.A. Buys 962,940 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Aug 21, 2024
pulisher
Aug 20, 2024

Changing Trial Design When Stepping Up From Second-Line To First-Line Treatment - Clinical Leader

Aug 20, 2024
pulisher
Aug 18, 2024

Head-To-Head Analysis: Agenus (NASDAQ:AGEN) versus Cardiff Oncology (NASDAQ:CRDF) - Defense World

Aug 18, 2024
pulisher
Aug 17, 2024

Cardiff Oncology (STU:XE7C) Cash Flow from Investing : €33.30 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 16, 2024

Cardiff Oncology to Present at Upcoming Investor Conferences in September - GuruFocus.com

Aug 16, 2024
pulisher
Aug 16, 2024

Take off with Cardiff Oncology Inc (CRDF): Get ready for trading - SETE News

Aug 16, 2024
pulisher
Aug 15, 2024

Vanguard Group Inc. Acquires 9,468 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

Gaining Ground: Cardiff Oncology Inc (CRDF) Closes Lower at 2.18, Down -3.11 - The Dwinnex

Aug 15, 2024
pulisher
Aug 13, 2024

The Cardiff Oncology Inc (CRDF) had a good session last reading, didn’t it? - US Post News

Aug 13, 2024
pulisher
Aug 12, 2024

Cardiff: Second Half Of 2024 mCRC Data Is Major Inflection Point (NASDAQ:CRDF) - Seeking Alpha

Aug 12, 2024
pulisher
Aug 12, 2024

Cardiff Oncology Inc: A Year of Highs, Lows, and Market Resilience - The InvestChronicle

Aug 12, 2024
pulisher
Aug 12, 2024

Earnings call: Cardiff Oncology Q2 2024 update on CRDF-004 trial and finances - Investing.com

Aug 12, 2024
pulisher
Aug 12, 2024

Cardiff Oncology, Inc. (NASDAQ:CRDF) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 12, 2024
pulisher
Aug 10, 2024

Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call Transcript - Seeking Alpha

Aug 10, 2024
pulisher
Aug 09, 2024

Balance Sheet Breakdown: Cardiff Oncology Inc (CRDF)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Aug 09, 2024
pulisher
Aug 09, 2024

Cardiff Oncology Inc (CRDF) Q2 2024 Earnings: EPS Misses Estimat - GuruFocus.com

Aug 09, 2024
pulisher
Aug 09, 2024

Cardiff Oncology: Q2 Earnings Snapshot - CTPost

Aug 09, 2024

Cardiff Oncology Inc Stock (CRDF) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$358.35
price down icon 0.05%
$21.90
price up icon 4.86%
$224.51
price up icon 2.79%
$66.83
price up icon 1.64%
$118.77
price up icon 0.47%
$542.08
price up icon 1.11%
Cap:     |  Volume (24h):